Abstract:e13517 Background: Clear cell renal cell carcinoma (ccRCC) represents the most common histological subtype of RCC, with poor response to chemotherapy and radiotherapy. Immunotherapy and novel therapies targeting angiogenesis signaling pathways have proved to be effective for RCC patients (pts). However, the comprehensive genomic features of ccRCC in Chinese pts have not been well understood. Methods: Deep sequencing targeting 450 cancer genes was performed on FFPE and matched blood samples collected from 39 Chinese ccRCC pts with a median age of 54 years (range 31-75) and a male-to-female ratio of 3.3. Genomic alterations (GAs) including single nucleotide variations, short and long insertions and deletions, copy number variations, and gene rearrangements were analyzed. Tumor mutation burden (TMB) and microsatellite instability (MSI) status were assessed by standard NGS algorithms. Results: In the Chinese cohort, the most common genomic alterations were detected in VHL (82.1%), PBRM1 (53.8%), SETD2 (20.5%), PTEN (15.4%), BAP1 (17.9%), TSC1/2 (15.4%), TP53 (10.3%), TERT (7.7%), MTOR (7.7%), KMT2C (7.7%), and CHD2 (7.7%). In total, 80% of the pts had one or more actionable GAs. The chromosome 3p tumor suppressors (VHL, PBRM1, and SETD2) were identified in 87% of the pts. PI3K/mTOR pathway alterations including PTEN, MTOR, TSC1/2 and PIK3CA mutations were detected in 30% of the pts. Compared with TCGA data (501 pts), we found higher mutation frequency of VHL, PBRM1, and PTEN in the current Chinese cohort. The median TMB value of our ccRCC pts was 5.6 muts/Mb (range: 0-58); 8.3% of the pts had TMB greater than or equal to 20 muts/Mb. Three ccRCC pts were identified as MSI-H. One pt with a novel MET fusion responded well to cabozantinib. Conclusions: Compared with the TCGA data set mostly based on Western population, our Chinese cohort revealed that the genomic alteration frequencies of chromosome 3p tumor suppressors (VHL, PBRM1, and SETD2) were higher compared with TCGA (VHL: 82.1% vs 49.3%; PBRM1: 53.8% vs 30.1%; SETD2: 20.5% vs 12.4%). The NGS-based comprehensive genomic profiling assay could detect all GAs, TMB, and MSI status simultaneously, and suggest personalized treatment options of targeted therapy and immunotherapy for ccRCC pts.

Germline Genetic Variations Inpdzd2anditpr2genes Are Associated with Clear Cell Renal Cell Carcinoma in Chinese Population

Cervical Carcinoma Risk Associate with Genetic Polymorphisms of NEIL2 Gene in Chinese Population and Its Significance As Predictive Biomarker

Genetic Variants in RKIP Are Associated with Clear Cell Renal Cell Carcinoma Risk in a Chinese Population.

Germline Genetic Variants in Somatically Significantly Mutated Genes in Tumors Are Associated with Renal Cell Carcinoma Risk and Outcome

Genetic variation in IGF1 predicts renal cell carcinoma susceptibility and prognosis in Chinese population

The Association of Rs710886 in Lncrna PCAT1 with Bladder Cancer Risk in a Chinese Population.

A Genome-Wide Association Study Identifies a Novel Susceptibility Locus for Renal Cell Carcinoma on 12P11.23.

Comprehensive Genomic Profiling in Chinese Patients with Clear Cell Renal Cell Carcinoma.

Genetic Scores Based on Risk-Associated Single Nucleotide Polymorphisms (snps) Can Reveal Inherited Risk of Renal Cell Carcinoma

A Genome-Wide Association Study of Renal Cell Carcinoma among African Americans.

Common Variation at 2q22.3 (ZEB2) Influences the Risk of Renal Cancer.

Association Analysis and Polygenic Risk Score Evaluation of 38 Gwas-Identified Loci in A Chinese Population with Parkinson'S Disease

An Evaluation Study of Reported Pancreatic Adenocarcinoma Risk-Associated SNPs from Genome-Wide Association Studies in Chinese Population

Genome-wide Association Study Identifies Multiple Risk Loci for Renal Cell Carcinoma

IL1 Genes Polymorphism and the Risk of Renal Cell Carcinoma in Chinese Han Population.

Two Novel PRKCI Polymorphisms and Prostate Cancer Risk in an Eastern Chinese Han Population

Genomic Alterations of Renal Cell Carcinoma and Clinical Implications in the Chinese Population

Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3

Genetic risk scores based on risk-associated single nucleotide polymorphisms can reveal inherited risk of bladder cancer in Chinese population.

A Functional Polymorphism C‐1310G in the Promoter Region of Ku70/XRCC6 is Associated with Risk of Renal Cell Carcinoma

Multilevel-analysis Identify a Cis-Expression Quantitative Trait Locus Associated with Risk of Renal Cell Carcinoma